Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|August 11, 2016
The HB22.7-vcMMAE antibody-drug conjugate has efficacy against non-Hodgkin lymphoma mouse xenografts with minimal systemic toxicityMastewal Abuhay, Jason Kato, Emily Tuscano, et al.
Journal of Hematology & Oncology|December 2, 2011
The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent mannerShiloh M Martin, Eric Churchill, Hayes McKnight, et al.
Plos One|January 6, 2018
A purified, fermented, extract of Triticum aestivum has lymphomacidal activity mediated via natural killer cell activationGustavo A Barisone, Robert T O'Donnell, Yunpeng Ma, et al.
Cancer Research|September 19, 2012
CD22 antigen is broadly expressed on lung cancer cells and is a target for antibody-based therapyJoseph M Tuscano, Jason Kato, David Pearson, et al.
British Journal of Haematology|March 11, 2014
Lenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphomaJoseph M Tuscano, Mrinal Dutia, Karen Chee, et al.
Molecular Pharmaceutics|April 26, 2012
Disulfide cross-linked micelles for the targeted delivery of vincristine to B-cell lymphomaJason Kato, Yuanpei Li, Kai Xiao, et al.
Molecular Imaging and Biology|October 25, 2008
Imaging and pharmacokinetics of (64)Cu-DOTA-HB22.7 administered by intravenous, intraperitoneal, or subcutaneous injection to mice bearing non-Hodgkin's lymphoma xenograftsShiloh M Martin, Robert T O'Donnell, David L Kukis, et al.
PET Clinics|July 5, 2024
Long-Axial Field-of-View PET Imaging in Patients with Lymphoma: Challenges and OpportunitiesClemens Mingels, Hande Nalbant, Hasan Sari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2021
Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent LymphomaJoseph M Tuscano, Christina Poh, Paul Kaesberg, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 3, 2021
Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer CenterMatthew E Tenold, Benjamin N Moskoff, Rajeev Krishnan, et al.
Pageof 7